Development of recombinant-based mass spectrometric immunoassay with application to resistin expression profiling

Kemmons A. Tubbs, Urban A. Kiernan, Eric E. Niederkofler, Dobrin Nedelkov, Allan L. Bieber, Randall W. Nelson

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

This report addresses the need for additional assays for human resistin (hRES) by developing a rational progression of the mass spectrometric immunoassay to incorporate recombinant proteins. The recombinant-based hRES mass spectrometric immunoassay (RES-MSIA) was initially developed for the qualitative analysis of the human resistin homodimer from normal (healthy) plasma samples. The method involved selective extraction and detection of both endogenous and recombinant resistant proteins. RES-MSIA was then applied to the rigorous quantification of resistin. The resistin standard addition curve was constructed from serially diluted concentrations of rhRES using endogenous hRES, inherent in the human plasma, as the internal reference standard (IRS). The roles of endogenous and recombinant resistin were subsequently reversed, using rhRES as the 1RS during RES-MSIA quantification. Concurrently, the relative ratio of hRES to rhRES was used as an ancillary technique to rapidly determine the relative concentration of hRES in each of plasma samples. Overall, normal hRES levels determined by RES-MSIA were found to be comparable to those selected and determined by ELISA. With regard to gender, female donor samples were slightly elevated over males. Four single cardiac samples were analyzed and found to have hRES concentrations approximately three times that of the normal. The recombinant-based RES-MSIA is rapid and is amendable to parallel high-throughput robotic processing of resistin related disease cohorts.

Original languageEnglish (US)
Pages (from-to)3271-3276
Number of pages6
JournalAnalytical Chemistry
Volume78
Issue number10
DOIs
StatePublished - May 15 2006

Fingerprint

Resistin
Plasma (human)
Plasmas
human RETN protein
Recombinant Proteins
Assays
Robotics
Throughput

ASJC Scopus subject areas

  • Analytical Chemistry

Cite this

Tubbs, K. A., Kiernan, U. A., Niederkofler, E. E., Nedelkov, D., Bieber, A. L., & Nelson, R. W. (2006). Development of recombinant-based mass spectrometric immunoassay with application to resistin expression profiling. Analytical Chemistry, 78(10), 3271-3276. https://doi.org/10.1021/ac060013g

Development of recombinant-based mass spectrometric immunoassay with application to resistin expression profiling. / Tubbs, Kemmons A.; Kiernan, Urban A.; Niederkofler, Eric E.; Nedelkov, Dobrin; Bieber, Allan L.; Nelson, Randall W.

In: Analytical Chemistry, Vol. 78, No. 10, 15.05.2006, p. 3271-3276.

Research output: Contribution to journalArticle

Tubbs, KA, Kiernan, UA, Niederkofler, EE, Nedelkov, D, Bieber, AL & Nelson, RW 2006, 'Development of recombinant-based mass spectrometric immunoassay with application to resistin expression profiling', Analytical Chemistry, vol. 78, no. 10, pp. 3271-3276. https://doi.org/10.1021/ac060013g
Tubbs, Kemmons A. ; Kiernan, Urban A. ; Niederkofler, Eric E. ; Nedelkov, Dobrin ; Bieber, Allan L. ; Nelson, Randall W. / Development of recombinant-based mass spectrometric immunoassay with application to resistin expression profiling. In: Analytical Chemistry. 2006 ; Vol. 78, No. 10. pp. 3271-3276.
@article{f2f5f0f7397c44258aa7706ecd065b0a,
title = "Development of recombinant-based mass spectrometric immunoassay with application to resistin expression profiling",
abstract = "This report addresses the need for additional assays for human resistin (hRES) by developing a rational progression of the mass spectrometric immunoassay to incorporate recombinant proteins. The recombinant-based hRES mass spectrometric immunoassay (RES-MSIA) was initially developed for the qualitative analysis of the human resistin homodimer from normal (healthy) plasma samples. The method involved selective extraction and detection of both endogenous and recombinant resistant proteins. RES-MSIA was then applied to the rigorous quantification of resistin. The resistin standard addition curve was constructed from serially diluted concentrations of rhRES using endogenous hRES, inherent in the human plasma, as the internal reference standard (IRS). The roles of endogenous and recombinant resistin were subsequently reversed, using rhRES as the 1RS during RES-MSIA quantification. Concurrently, the relative ratio of hRES to rhRES was used as an ancillary technique to rapidly determine the relative concentration of hRES in each of plasma samples. Overall, normal hRES levels determined by RES-MSIA were found to be comparable to those selected and determined by ELISA. With regard to gender, female donor samples were slightly elevated over males. Four single cardiac samples were analyzed and found to have hRES concentrations approximately three times that of the normal. The recombinant-based RES-MSIA is rapid and is amendable to parallel high-throughput robotic processing of resistin related disease cohorts.",
author = "Tubbs, {Kemmons A.} and Kiernan, {Urban A.} and Niederkofler, {Eric E.} and Dobrin Nedelkov and Bieber, {Allan L.} and Nelson, {Randall W.}",
year = "2006",
month = "5",
day = "15",
doi = "10.1021/ac060013g",
language = "English (US)",
volume = "78",
pages = "3271--3276",
journal = "Analytical Chemistry",
issn = "0003-2700",
publisher = "American Chemical Society",
number = "10",

}

TY - JOUR

T1 - Development of recombinant-based mass spectrometric immunoassay with application to resistin expression profiling

AU - Tubbs, Kemmons A.

AU - Kiernan, Urban A.

AU - Niederkofler, Eric E.

AU - Nedelkov, Dobrin

AU - Bieber, Allan L.

AU - Nelson, Randall W.

PY - 2006/5/15

Y1 - 2006/5/15

N2 - This report addresses the need for additional assays for human resistin (hRES) by developing a rational progression of the mass spectrometric immunoassay to incorporate recombinant proteins. The recombinant-based hRES mass spectrometric immunoassay (RES-MSIA) was initially developed for the qualitative analysis of the human resistin homodimer from normal (healthy) plasma samples. The method involved selective extraction and detection of both endogenous and recombinant resistant proteins. RES-MSIA was then applied to the rigorous quantification of resistin. The resistin standard addition curve was constructed from serially diluted concentrations of rhRES using endogenous hRES, inherent in the human plasma, as the internal reference standard (IRS). The roles of endogenous and recombinant resistin were subsequently reversed, using rhRES as the 1RS during RES-MSIA quantification. Concurrently, the relative ratio of hRES to rhRES was used as an ancillary technique to rapidly determine the relative concentration of hRES in each of plasma samples. Overall, normal hRES levels determined by RES-MSIA were found to be comparable to those selected and determined by ELISA. With regard to gender, female donor samples were slightly elevated over males. Four single cardiac samples were analyzed and found to have hRES concentrations approximately three times that of the normal. The recombinant-based RES-MSIA is rapid and is amendable to parallel high-throughput robotic processing of resistin related disease cohorts.

AB - This report addresses the need for additional assays for human resistin (hRES) by developing a rational progression of the mass spectrometric immunoassay to incorporate recombinant proteins. The recombinant-based hRES mass spectrometric immunoassay (RES-MSIA) was initially developed for the qualitative analysis of the human resistin homodimer from normal (healthy) plasma samples. The method involved selective extraction and detection of both endogenous and recombinant resistant proteins. RES-MSIA was then applied to the rigorous quantification of resistin. The resistin standard addition curve was constructed from serially diluted concentrations of rhRES using endogenous hRES, inherent in the human plasma, as the internal reference standard (IRS). The roles of endogenous and recombinant resistin were subsequently reversed, using rhRES as the 1RS during RES-MSIA quantification. Concurrently, the relative ratio of hRES to rhRES was used as an ancillary technique to rapidly determine the relative concentration of hRES in each of plasma samples. Overall, normal hRES levels determined by RES-MSIA were found to be comparable to those selected and determined by ELISA. With regard to gender, female donor samples were slightly elevated over males. Four single cardiac samples were analyzed and found to have hRES concentrations approximately three times that of the normal. The recombinant-based RES-MSIA is rapid and is amendable to parallel high-throughput robotic processing of resistin related disease cohorts.

UR - http://www.scopus.com/inward/record.url?scp=33646738333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646738333&partnerID=8YFLogxK

U2 - 10.1021/ac060013g

DO - 10.1021/ac060013g

M3 - Article

C2 - 16689526

AN - SCOPUS:33646738333

VL - 78

SP - 3271

EP - 3276

JO - Analytical Chemistry

JF - Analytical Chemistry

SN - 0003-2700

IS - 10

ER -